Pages that link to "Q30249819"
Jump to navigation
Jump to search
The following pages link to Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. (Q30249819):
Displaying 50 items.
- Kidney disease and obesity: epidemiology, mechanisms and treatment. (Q30239002) (← links)
- Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data. (Q31157315) (← links)
- Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England (Q36300946) (← links)
- Precocious obesity predisposes the development of more severe cisplatin-induced acute kidney injury in young adult mice (Q36328309) (← links)
- Activation of FXR protects against renal fibrosis via suppressing Smad3 expression (Q37419118) (← links)
- Consequences of morbid obesity on the kidney. Where are we going? (Q37511029) (← links)
- Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial (Q38377453) (← links)
- KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors (Q38652031) (← links)
- Determinants of glomerular filtration rate following bariatric surgery in individuals with severe, otherwise uncomplicated, obesity: an observational, prospective study (Q38848740) (← links)
- Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage (Q38962777) (← links)
- The metabolic syndrome and chronic kidney disease (Q39056509) (← links)
- Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids (Q39096936) (← links)
- What are we missing in the clinical trials of focal segmental glomerulosclerosis? (Q39229298) (← links)
- Single-Nephron Glomerular Filtration Rate in Healthy Adults (Q40160143) (← links)
- Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats (Q41547300) (← links)
- Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats. (Q42316455) (← links)
- The effects of body weight loss and gain on arterial hypertension control: an observational prospective study (Q42633810) (← links)
- Can Renal Biopsy Be Used to Estimate Total Nephron Number? (Q45055532) (← links)
- Evaluation of inducible nitric oxide synthase inhibition on kidney function and structure in high-fat diet-induced kidney disease. (Q46301293) (← links)
- The NLPR3 inflammasome and obesity-related kidney disease. (Q47130640) (← links)
- Weight Loss in Advanced Chronic Kidney Disease: Should We Consider Individualised, Qualitative, ad Libitum Diets? A Narrative Review and Case Study (Q47141336) (← links)
- Eligibility and Success Criteria for Bariatric/Metabolic Surgery (Q47288646) (← links)
- Effect of Bariatric Surgery on CKD Risk (Q47563194) (← links)
- Associations between body mass index and the risk of renal events in patients with type 2 diabetes (Q47674377) (← links)
- Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention (Q47676923) (← links)
- SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology (Q47692117) (← links)
- FSGS as an Adaptive Response to Growth-Induced Podocyte Stress (Q47760613) (← links)
- Complications of obesity. (Q47809889) (← links)
- Mitochondria Damage and Kidney Disease (Q48026176) (← links)
- Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo (Q48053473) (← links)
- Antilipotoxicity Activity of Osmanthus fragrans and Chrysanthemum morifolium Flower Extracts in Hepatocytes and Renal Glomerular Mesangial Cells. (Q48189832) (← links)
- AGEs-RAGE overexpression in a patient with smoking-related idiopathic nodular glomerulosclerosis. (Q48225516) (← links)
- Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment (Q48698019) (← links)
- Immunologic and endocrine functions of adipose tissue: implications for kidney disease (Q49334065) (← links)
- The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice (Q49715387) (← links)
- Alteration of Connexin43 expression in a rat model of obesity-related glomerulopathy (Q49792287) (← links)
- Animal models of obesity and diabetes mellitus (Q49952246) (← links)
- The Incidence of Primary vs Secondary Focal Segmental Glomerulosclerosis: A Clinicopathologic Study (Q50127500) (← links)
- Novel inhibitors of the cellular RAS components, Poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. (Q52573051) (← links)
- CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. (Q52589075) (← links)
- One-Year Outcomes of a Cohort of Renal Transplant Patients Related to BMI in a Steroid-Sparing Regimen. (Q52656962) (← links)
- Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation. (Q52661291) (← links)
- Renal Complications of Lipodystrophy: a closer look at the natural history of kidney disease. (Q52714201) (← links)
- Podocyte Growing Pains in Adaptive FSGS. (Q53158267) (← links)
- Life with one kidney. (Q55081863) (← links)
- Glomerular Hyperfiltration as Predictor of Cardiometabolic Risk Factors among Children and Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult-V Study. (Q55398406) (← links)
- Role of connecting tubule glomerular feedback in obesity related renal damage (Q57282416) (← links)
- Chronic kidney disease (Q57701181) (← links)
- Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study (Q58590575) (← links)
- Klotho and Aminopeptidases as Early Biomarkers of Renal Injury in Zucker Obese Rats (Q59335575) (← links)